Life Sciences Analytics Consulting
Life sciences analytics for pharma, biotech, and CROs. FDA ready pipelines, clinical data governance, and R&D analytics infrastructure built to scale.
Topics
- life sciences data analytics consulting
- clinical data governance
- FDA submission data
- CDISC data pipelines
- pharma analytics consulting
- biotech data infrastructure
Work delivered in this industry
Mid-Size Pharmaceutical Company
We built a clinical trial data governance system that cut FDA submission prep time from 14 weeks to 3 weeks.
14 to 3 weeks FDA submission preparation time.
Medical Device Company
Launched analytics platform 8 weeks early to optimize territories and drive $2.4M in revenue adjustments
$2.4M Territory optimization opportunity identified pre-launch.
Clinical-Stage Biotech
We developed R&D portfolio analytics covering 8 programs to give the board a clear, consolidated view of pipeline value.
3 weeks to 2 days Board reporting preparation time.
Specialty Pharmaceutical Company
We automated the pharmacovigilance data pipeline, cutting adverse event processing from 18 days to 4 hours.
18 days to 4 hours Adverse event processing time.
What clients in this industry usually arrive with
- Reporting cannot be trusted, described as sales and finance numbers do not match or inconsistent KPI reporting. Resolved by Metric governance, data cleaning, master data management, data engineering.
- Reporting takes too much work, described as automate monthly reporting or combine reports from multiple systems. Resolved by Executive reporting, integrations, ERP consolidation.
- Employees waste time finding information, described as search internal company documents or find policies and procedures quickly. Resolved by Knowledge assistant, RAG, unstructured data platform.
- Systems require manual handoffs, described as eliminate manual data entry between systems or automate approval workflows. Resolved by API integration, workflow automation, human review design.
- AI projects are not delivering value, described as measure AI ROI or AI pilot not moving to production. Resolved by Strategy, readiness assessment, AI PMO, adoption.
- AI is too risky to deploy, described as AI confidential data protection or control AI agent permissions. Resolved by Governance, AI security, agent identity, evaluation.
Other industries
- Aerospace & Defense Analytics Consulting
- Cannabis Analytics Consulting
- Energy & Utilities Analytics Consulting
- Financial Services Analytics Consulting
- Funding & Brokerage Analytics Consulting
- Gaming & Hospitality Analytics Consulting
- Government Analytics Consulting
- Higher Education Analytics Consulting
- Insurance Analytics Consulting
- Legal Services Analytics Consulting
- Logistics & Supply Chain Analytics
- Manufacturing Analytics Consulting
- Marketing & Advertising Analytics
- Media & Entertainment Analytics
- Non-Profit Analytics Consulting
- Retail & E-Commerce Data Analytics Consulting
- Semiconductor Analytics Consulting
- Technology & SaaS Analytics Consulting
- Telecommunications Analytics Consulting
- Wealth Management Analytics Consulting